This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Unit for Hours:H

Unit for Minutes: M

Loading text: $loading

Filter redirection page URL: /en-gb/events/

Login overlay needed?:

Filter Tags:Product|Therapy

Filter Tags values when filtered by all Tags:All Medical indications|All Products|All Therapy Area

OutofBox filter category name:Format

Filter Reset all button text:Reset All

Filter Apply button text:Apply

Events registration success message: Registration successfull

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successfull

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Show More Naivagation Values: 10|25|50

Previous Text label: Previous

Next Text label: Next

Show Text label: Show:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:Not Provided

Month Names:January,February,March,April,May,June,July,August,September,October,November,December

Month Names Short:Jan,Feb,Mar,Apr,May,Jun,Jul,Aug,Sep,Oct,Nov,Dec

Day Names:Sunday,Monday,Tuesday,Wednesday,Thursday,Friday,Saturday

Day Names Short:Sun,Mon,Tue,Wed,Thu,Fri,Sat

Day Names Min:Sun,Mon,Tue,Wed,Thu,Fri,Sat

Date Format:mm/dd/yy

Events Filter Date Placeholder:dd-mm-yyyy

Title

Video player requires JavaScript enabled.
Description
287 result(s)

Ellipta inhaler products | GSKpro

27-11-2015
Ellipta inhaler information for UK healthcare professionals including getting started, how to use the Ellipta inhaler and top tips for your patients.

Home | GSKpro

For UK healthcare professionals. Get access to patient resources including samples and demo devices, exclusive webinars and updates on the latest in respiratory and more.

Anoro Ellipta

oneClickSuccessPage

oneClickErrorPage

Consent Management

Registration Email Validation

Medicines management and optimisation

Access bespoke financial and prescribing data for your health economy. Identify variability, track and optimise your implementation projects

GSK Highlights from ATS 2020 | GSKpro

GSK Highlights from The American Thoracic Society (ATS) Congress 2020

Respiratory

Overview of COPD and severe asthma.

Oncology Expert Insights

Expert opinion on ovarian cancer treatment to support UK healthcare professionals

Ordering and delivery

Find out how to set up an account and start ordering GSK vaccines.

Therapy areas

GSK UK therapy areas page allows healthcare professionals to find GSK product information by therapy area.

Temporary Password Sent

Forgotten Password

Reset Password Confirmation

Login

Login

Login

Unsubscribe

Contact Us Confirmation

Cost | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) price information to support UK healthcare professionals

Guidelines |Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)| GSKPro

Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Safety Information | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Lung Function | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Home | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Dosing & Administration | Nucala (mepolizumab)

Nucala (mepolizumab) can be administered at home or in clinic. Read more about dosing and administration here.

Identifying Patients | Nucala (mepolizumab)

Understand how to identify which patients with severe asthma are suitable for treatment with Nucala (mepolizumab) as an add-on treatment.

Expert Perspectives | Nucala (mepolizumab)

See what the experts have to say about Nucala (mepolizumab).

Paediatric Patients | Nucala (mepolizumab)

See the data behind and safety profile of Nucala (mepolizumab) in paediatric patients with severe asthma.

Safety Information | Nucala (mepolizumab)

See the safety profile of Nucala (mepolizumab) in adults and adolescents.

Efficacy | Nucala (mepolizumab)

Read the clinical data about Nucala (mepolizumab).

Nucala (meplizumab) | Severe eosinophilic asthma

Learn more about Nucala (mepolizumab) as an add-on treatment for patients with severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older.

GSK support for healthcare professionals in response to COVID-19

Information for healthcare professionals on GSK’s response to COVID-19, where to find support and relevant resources.

Head-to-head data | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) head-to-head data to support UK healthcare professionals

Guidelines | Anoro▼ Ellipta (umeclidinium / vilanterol)

COPD guidelines information relevant to Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals

Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) information to support UK healthcare professionals

Anoro

vs. LAMA | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA head-to-head data to support UK healthcare professionals

vs. LAMA/LABA | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA/LABA head-to-head data to support UK healthcare professionals

Anoro Patient | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) patient profile information intended to support UK healthcare professionals

Molecules | Anoro▼ Ellipta (umeclidinium / vilanterol)

Information about the molecules in Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals

Guidelines

Head-to-head data

Webinars & events | GSKpro

A collection of promotional events and webinars featuring experts for UK healthcare professionals

Severe Asthma Referrals: This is Real Life Part 2

Severe Asthma Referrals: This is Real Life

Homecare: This is Real Life

Video Testimonials: I've Seen Meningitis

Video testimonials from healthcare professionals about the impact of meningitis

Need more information?

Ellipta critical error studies in COPD

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients

Experts’ perspectives | Anoro▼ Ellipta (umeclidinium / vilanterol)

Experts' perspectives and patient case study videos relevant to the LAMA/LABA class to support UK healthcare professionals

Vaccines

GSK UK information about our vaccines and disease awareness campaigns

Unsubscribe-lite

Account Deleted

Access GSK Page

DECTOVA▼

Zanamivir IV</br> Influenza

ZEJULA▼

Niraparib<br>Oncology

Data Layer test

MS Testing Popup

Basket

Tackle Meningitis

covid-19

Checkout

Avamys UK how to use guide

Duac

Spotchickenpox

FendrixTile1

LamictalTile2

MenitorixTile2

EumovateView PIL

CutivateTile2

Benlysta View Spc

GSK vaccines support

Ventolin View SPC

ReQuip Tile1

vaccines.co.uk

Synflorix Tile1

Naramig Tile1

Flixonase View SPC

Cervarix View Pil

Cervarix EPAR

FluarixTile1

Bexseo_pil

Strimvelis SPC

Adartrel - View SPC

Varilrix View SPC

view spc zinacef

View pil zovirax

ReQuip Tile2

Duac PIL

FortamTil1

ImigranTile1

Ventolin View PIL

Synflorix Tile2

Wellvone view spc

Duac SPC

Priorix Tile2

Requip Xl Tile2

Avodart View Pil

Relenza Tile2

Valtrex View PIL

Boostrix view pil

LamictalTile1

Combodart view spc

Varilrix View PIL

AugmentinDuoTile2

View pil zyban

MenitorixTile1

View Spc Zantac

Betnovate View SPC

Strimvelis PIL

Tacklemeningitis

Malarone ViewSPC

Benlysta EPAR

Fendrix EPAR

Nimbex/NimbexForte Tile2

Avodart View Spc

Wellvone-view-pil

AnectineTile2

AugmentinTile1

DermovateView PIL

Cutivate Tile1

View SPC zovirax

Adartrel View PIL

view PIL

LiskonumTile1

BetnovateView PIL

Malarone ViewPIL

Relenza Tile1

Bactroban View SPC

DaraprimTile2

ViiV Exchange website

AugmentinTile2

view spc zyban

Adartrel EPAR

View SPC Mivacron

view pil zinacef

View SPC

LiskonumTile2

View Pil Mivacron

Requip Xl Tile1

Benlysta View pil

view pil zantac

Test

Flixotide View SPC

FendrexTile2

Flixonase View PIL

FlolanTile1

AugmentinDuoTile1

Serevent ViewPIL

Dermovate View SPC

Combodart view pil

Bactroban View PIL

FluarixTile2

Infanrix-IPV+Hib tile 1

Integrilin EPAR

Priorix Tile1

Seroxat Tile1

Serevent ViewSPC

view SPC

Nimbex/NimbexForte Tile1

Trimovate View SPC

FlixotideView PIL

FortamTile2

Beconase View PIL

AnectineTile1

Spotchickenpox

FlolanTile2

Trimovate View PIL

View pil

Eumovate View SPC

ImigranTile2

IntegrilinTile2

Valtrex View SPC

Synflorix EPAR

view pil zinacef

Infanrix-IPV+Hib tile 2

Naramig Tile2

Seroxat Tile2

Cervarix View Spc

Beconase View SPC

Vaccines

DaraprimTile1

IntegrilinTile1

Boostrix view spc

Registration Token

COPD

Severe Asthma

ellipta-overview

Ellipta

Oncology

Update Password Confirmation

Update Password

Token Sent

Send Confirmation Token

Login

MS Testing

Incruse Ellipta

Trelegy Ellipta

Home

Trelegy Patient

clinical-data

quality_of_life_impact-new

lung_function_impact-new

exacerbations_impact-new

Efficacy

Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.

Home

Adults and adolescents

Sirius graph

Mensa graph

Musca graph

Dose & Device | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) dosing and device information to support UK healthcare professionals

Contact | GSKpro UK

GSK UK contact page for healthcare professionals.

Coming soon | GSKpro

This page is under construction. If you require assistance, please connect with our Customer Support team via live chat or request to be contacted by a suitable GSK contact.

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) I COPD I GSKPro

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Zejula ▼ (niraparib)

COPD expert perspectives

Watch GSK Global Medical Experts approach key issues in COPD treatment, offering solutions for UK healthcare professionals.

BLENREP▼

belantamab mafodotin<br> Oncology

BENLYSTA▼

belimumab<br> Musculoskeletal

SHINGRIX

Safety | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Patient Profiles | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Vaccinate with SHINGRIX | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Home | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Efficacy against Shingles

Optimising Prescribing for COPD Patients; What Matters Most?| GSKpro

Registration page for a webinar on ‘Optimising Prescribing for COPD Patients’ for UK Health Professionals

FAQ | Supply | GSKpro

Frequently asked questions around the supply and availability of GSK medicines and vaccines.

GSK Highlights from ERS 2020 | GSKpro

GSK Highlights from European Respiratory Congress 2020

Resources | GSKpro

Support your patients and practice with these healthcare resources, ranging from training devices to patient support information.

Homecare: Severe Asthma Real World Experience

Zejula ▼ (niraparib)

Zejula ▼ (niraparib) product information for healthcare professionals detailing the top line efficacy, safety and dosing data

bexsero

Safety | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for healthcare professionals

Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for healthcare professionals

Bexsero GSKpro Invasive meningococcal disease

Bexsero prescribing information for healthcare professionals

Dosing and administration | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for healthcare professionals

Real world evidence | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for healthcare professionals

Clinical Information

Adverse Events

Reset Password

Report a possible side effect | GSKpro

Information for UK healthcare professionals on how to report an adverse event related to a GSK product

Molecules | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Products | GSKpro

GSK product information for UK healthcare professionals

SHINGRIX▼

Herpes zoster vaccine recombinant, adjuvanted<br> Vaccines

Scientific Rationale | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Discontinued products | GSK Pro

Discontinued products

Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

PHN-Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

HRQoL | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Dosing & Device | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) dosing & device information to support UK healthcare professionals

Safety | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals

Cost | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals

Tabs

Request a contact

Contact us form for UK healthcare professionals to contact GSK

patient resource

Resources | Nucala (mepolizumab) | For Healthcare Professionals Only

View the resources available to support your patients prescribed Nucala (mepolizumab).

Registration

Identifying patients | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Supply

Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

Show more

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.